Szemészet, 2015 (152. évfolyam, 1-4. szám)
2015-03-01 / 1. szám
Retinal nerve thickness layer evaluation after different I Irodalom 1. Boldt HC, Munden PM, Folk JC, Mehaffey MG. Visual field defects after macular hole surgery. Am J Ophthalmol 1996; 122: 371-381. 2. Ebisawa N, Mori K, Yoneya S. Thickness of retinal nerve fibre layer decreases after vitreous surgery for idiopathic macular hole. Jpn J Ophthalmol 2000; 104: 142-147. 3. Ejstrup R, la Cour M, Heegaard S, Kiilgaard JF Toxicity profiles of subretinal indocyanine green, Brilliant Blue G, and triamcinolone acetonide: a comparative study. Graafes Arch Clin Ophthalmol 2012; 250: 6B9-677. 4. Farah ME, Maia M, Rodrigues EB. Dyes in ocular surgery: principles for use in chromovitrectomy. Am J Ophthalmol 2009; 148: 332-340. 5. Ferencz M, Somfai GM, Farkas A, et a I. Functional assessment of the possible toxicity of indocyanine qreen dye in macular hole surqery. Am J Ophthalmol 2006; 142 (5): 765-70. 6. Gass CA, Haritoglou C, Schaumberger M, Kampik A. Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane. Graafe's Arch Clin Exp Ophthalmol 2003; 241: 716-720. 7. Hibi N, Kondo M, Ishikawa K, et a I. Transient increase of retinal nerve fiber layer thickness after macular hole surgery. Int Ophthalmol 2014; 34 (3): 575-81. 8. Hutton WL, Fuller DG, Snyder WB, et a I. Visual field defects after macular hole surgery: a new finding. Ophthalmol 1996; 103: 2152-2158. 9. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol 1991; 109: 654-659. 10. Kiilgaard JF, Nissen MH, la Cour M. An isotonic preparation of 1 mg/ml indocyanine green is not toxic to hyperconfluent ARPE19 cells, even after prolonged exposure. Acta Ophthalmol Scand 2006; 84: 42-46. 11. Kim KY, Yu SY, Kim MS, Kim ES, Kwak HW. Changes of parafoveal retinal nerve fiber layer thickness analyzed by spectral-domain optical coherence tomography after pars plana vitrectomy. Retina 2013; 33 (4): 776-84. 12. McCannel CA, Ensminger JL, Diehl NN, Hodge DN. Population based incidence of macular holes. Ophthalmology 2009; 116: 1366-1369. 13. Narayanan R, Mungeal JK, Kenney MC, et al. Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithel cells. Invest Ophthalmol Vis Sei 2006; 47: 722-728. 14. Nomoto H, Shiraga F Yamaji H, et al. Macular hole surgery with tramcinolone acetonide-assisted internal limiting membrane peeling: one-year results. Retina 2008; 28: 427-432. 15. Papp A, Pregun T, Szabó A, et al. Intravitreális triamcinolon-acetonid a diffúz diabeteses macula-oedema kezelésében. Szemészet 2007; 144 [11: 21-26. 16. Rodrigues EB, Meyer CH, Kroll P Chromovitrectomy: a new field in vitreoretinal surgery. Graafes Arch Clin Exp Ophthalmol 2005; 243: 291-293. 17. Ruiz-Moreno JM, Montero JA, Bayon A, et al. Retinal toxicity of intravitreal triamcinolone acetonide at high doses in the rabbit. Exp Eye Res 2007; 84 342-348. 18. Shah GK, Rosenblatt BJ, Blinder KJ, et al. Triamcinolone-assisted internal limiting membrane peeling. Retina 2005; 25: 972-975. 19. Spiteri Cornish K, Lois N, Scott N, et al. Vitrectomy with internal limiting membrane (ILM) peeling versus vitrectomy with no peeling for idiopathic fullthickness macular hole (FTMH). Cochrane Database Syst Rev 2013 Jun 5; 6: CD009306. 20. Stanescu-Segall D, Jackson TL. Vital staining with indocyanine green: a review of the clinical and experimental studies relating to safety. Eye 2009: 23: 504-518. 21. Steel DWH, Lotery AJ. Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment. Eye 2013; 27: S1-S21. 22. Tóba Y, Machida S, Kurosaka D. Comparisons of retinal nerve fiber layer thickness after indocyanine green, brilliant blue G, or triamcinolone acetonideassisted macuar hole surgery. J Ophthalmol 2014; 2014: 187308. 23. Tuzson R, Varsányi В, Vince Nagy B, et al. Role of multifocal electroretinography in the diagnosis of idiopathic macular hole. Invest Ophthalmol Vis Sei 2010; 51 (31:1666-70. 24. von Jagow B, Höing A, Gandorfer A, et al. Functional outcome of indocyanine green-assisted macular surgery. Retina 2009; 29: 1249-56. 25. Yamashita T, Uemura A. Kita H, Sakamoto T. Analysis of the retinal nerve fiber layer after indocyanine green-assisted vitrectomy for idiopathic macular holes. Ophthalmology 2006; 113: 280-284. Levelezési cí Dn Lukács Regina, 1Q85 Budapest, Mária u. 39. E-mail: Iukacs.regina85@gmail.com TROPHOSAN Visiobalance Időskori makuladegenerációs betegek étrendjének kiegészítésére Forgalmazó: Dr. Kocsis & Hoffmann Pharma Kft. 1024 Budapest, Retek utca 32.; Tel.: +361 438 0257; e-mail: drkh@drkh.hu; Gyártó: Protina Pharm. GmbH 85737 Ismaning, Adalperostrasse 37. Németország OÉT1 nyilvántartási száma: 1739/2013. www.trophosan.hu Kapható a gyógyszertárakban és a fitotékákban. Speciális - gyógyászati célra szánt - tápszer A TROPHOSAN Visiobalance kapható havi ill. 3 havi kiszerelésben. A napi 2x2, azaz a 4 kapszula összetétele összehasonlítva az AREDS formulával: / C-vitamin 500 mg / E-vitamin 400 IU / cink (oxid) 80 mg / réz (citrát) 2 mg / béta-karotin 7,5 mg / lutein 6 mg Hamarosan kapható az AREDS 2 tanulmány szerinti formula! ЕВВЕЕЕШб Speciális - gyógy. makulad betegek er^-
